Clinical Trial Update: SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot [EARLY_Phase 1]

View source ↗

Summary

An EARLY_PHASE1 trial evaluating SGLT2 inhibitors for acute kidney injury has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Minnesota | Conditions: Acute Kidney Injury | EARLY_Phase 1 | Status: TERMINATED